Roche Holding
CHF 355.80Change from previous close: −0.84%Absolute change: −CHF 3.00
At a glance
- Revenue growth
- +1.54%
- 2025 vs 2024
- Net income growth
- +55.61%
- 2025 vs 2024
- Net margin
- 20.3%
- 2024: 13.3%
Financial data
Amounts in millions of CHF; per-share values in CHF; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 18,852 | 20,094 | 16,095 | 17,803 | — |
| Depreciation and amortization | 3,386 | 3,423 | 3,464 | 3,844 | — |
| Capital expenditure | -5,779 | -5,009 | -4,649 | -4,552 | — |
| Investing cash flow | -8,543 | -11,393 | -10,643 | -2,924 | — |
| Financing cash flow | -11,368 | -6,819 | -4,239 | -16,275 | — |
| Dividends paid | -7,731 | -7,650 | -7,590 | -7,446 | — |
| Share repurchases | — | — | — | 0.0 | -18,991 |
| Debt issued | 2,575 | 7,915 | 8,342 | 8,442 | — |
| Debt repaid | -3,386 | -3,387 | -1,751 | -15,433 | — |
| Effect of exchange rates | -334 | -283 | -828 | -463 | — |
| Net change in cash | -1,059 | 1,882 | 1,213 | -1,396 | — |
| Free cash flow | 13,073 | 15,085 | 11,446 | 13,251 | — |